NASDAQ:BOLT
Bolt Biotherapeutics
- Stock
Last Close
1.10
03/05 20:00
Market Cap
40.62M
Beta: 0.99
Volume Today
38.14K
Avg: 250.78K
PE Ratio
−0.60
PFCF: −0.56
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.00 - | 0.00 11.84% | 0.00 17.50% | 0.03 514.18% | 0.05 96.00% | ||
cash per share | 1.45 - | 2.49 71.97% | 0.72 71.19% | 5.61 682.23% | 4.52 19.41% | 0.00 99.94% | |
company equity multiplier | -1.00 - | -1.06 5.46% | -0.44 58.03% | 1.23 377.42% | 1.33 7.96% | 1.42 6.70% | |
days of inventory outstanding | |||||||
days of payables outstanding | |||||||
days of sales outstanding | |||||||
dividend yield | |||||||
ebit per revenue | -144.04 - | -212.91 47.81% | -73.64 65.41% | -15.77 78.59% | -9.67 38.64% | ||
ebt per ebit | 1.00 - | 0.98 1.22% | 1.23 25.43% | 1.06 13.95% | 0.98 8.20% | 0.91 6.89% | |
effective tax rate | -0.00 - | 0.02 558.06% | -0.19 1,302.57% | -0.06 69.04% | 0.03 142.87% | ||
enterprise value multiple | -25.88 - | -13.90 46.31% | -27.95 101.10% | -1.87 93.32% | -0.70 62.58% | -555.92 79,478.04% | |
fixed asset turnover | 0.02 - | 0.01 24.47% | 0.04 192.02% | 0.20 387.81% | 0.33 62.87% | ||
free cash flow per share | -1.08 - | -1.92 77.89% | -1.59 17.26% | -1.79 12.69% | -2.10 17.36% | -0.00 99.91% | |
gross profit margin | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | ||
interest coverage | 40.63 - | ||||||
inventory turnover | |||||||
long term debt to capitalization | -0.18 - | -0.10 46.36% | 0.08 181.91% | 0.11 31.25% | 0.13 27.01% | ||
net income per ebt | 1 - | 0.98 1.58% | 1.19 20.92% | 1.06 11.03% | 0.97 7.94% | 1 2.59% | |
net profit margin | -139.56 - | -312.87 124.19% | -82.85 73.52% | -14.99 81.91% | -8.79 41.39% | ||
operating cash flow per share | -1.05 - | -1.88 79.65% | -1.49 21.11% | -1.72 15.72% | -2.05 19.13% | -0.00 99.91% | |
operating profit margin | -144.04 - | -212.91 47.81% | -73.64 65.41% | -15.77 78.59% | -9.67 38.64% | ||
payables turnover | |||||||
pretax profit margin | -141.80 - | -262.89 85.40% | -78.25 70.24% | -15.38 80.35% | -8.79 42.87% | ||
price fair value | -18.99 - | -9.81 48.35% | -9.76 0.56% | 0.65 106.67% | 0.28 56.46% | 375.63 132,551.76% | |
receivables turnover | |||||||
return on assets | -0.73 - | -0.62 14.63% | -1.55 150.73% | -0.34 78.15% | -0.38 11.12% | -0.43 14.88% | |
return on capital employed | -0.88 - | -0.78 11.52% | -1.39 79.13% | -0.32 76.76% | -0.44 36.19% | -0.55 23.94% | |
return on equity | 0.73 - | 0.65 9.96% | 0.69 5.23% | -0.42 160.61% | -0.50 19.97% | -0.61 22.58% | |
total debt to capitalization | -0.00 - | -0.29 11,254.99% | -0.12 59.52% | 0.09 176.74% | 0.12 31.27% | 0.15 30.55% |
All numbers in USD (except ratios and percentages)